Dusseldorf - Delayed Quote EUR
Cresco Labs Inc (6CQ.DU)
0.7250
+0.1735
+(31.46%)
At close: April 25 at 10:28:01 AM GMT+2
Loading Chart for 6CQ.DU
- Previous Close
0.5515 - Open
0.6720 - Bid --
- Ask --
- Day's Range
0.6720 - 0.7250 - 52 Week Range
0.4646 - 2.1000 - Volume
500 - Avg. Volume
120 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 13, 2025 - May 19, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 6CQ.DU
View MorePerformance Overview: 6CQ.DU
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
6CQ.DU
6.15%
S&P/TSX Composite index (^GSPTSE)
0.37%
1-Year Return
6CQ.DU
61.74%
S&P/TSX Composite index (^GSPTSE)
12.91%
3-Year Return
6CQ.DU
84.83%
S&P/TSX Composite index (^GSPTSE)
17.60%
5-Year Return
6CQ.DU
91.87%
S&P/TSX Composite index (^GSPTSE)
71.36%
Compare To: 6CQ.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.4378
+12.23%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.2340
+7.34%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.2200
+12.06%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
3.7400
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
3.8920
-4.89%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.1550
+7.92%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.4900
+18.63%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.29
+15.09%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.28
+14.73%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: 6CQ.DU
View MoreValuation Measures
As of 4/25/2025
Market Cap
261.73M
Enterprise Value
705.02M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.39
Price/Book (mrq)
0.60
Enterprise Value/Revenue
1.10
Enterprise Value/EBITDA
6.99
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--